Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
September 19, 2023 12:37 PM 3 min read

SAFE Banking Act Headcount Challenge: Can It Reach 60 Votes in the Senate? Analyst Tally

by Nicolás Jose Rodriguez Benzinga Staff Writer
Follow

Zuanic & Associates' latest report outlines a roadmap for the SAFE Banking Act in the US cannabis industry, emphasizing the significance of rescheduling, US exchange uplisting, and a potential "Cole Memo II" (Garland Memo) as more critical catalysts than the SAFE Act itself.

Join us at the 17th Benzinga Cannabis Capital Conference in Chicago on September 27-28 for a chance to meet Pablo Zuanic, chief analyst at Zuanic & Associates.

On The Cole Memo II

  • The 2013 Cole Memo, named after former Obama-appointed Deputy Attorney General James Cole, adopted a hands-off approach to federal marijuana prosecutions in states with marijuana-friendly policies. It was rescinded in 2018 under Trump, giving federal prosecutors more discretion in marijuana-related cases.
  • AG Merrick Garland's stance coincides with a hands-off approach, suggesting a potential return to the Cole Memo's principles. This parallels the trend of state-level cannabis legalization.

Road Steps And Catalysts Ahead

According to Zuanic, delays in the mark-up vote could, potentially, signify positive developments. The SAFE Act filed jointly in both the House and Senate in 2023, has gained bipartisan support, and the delays may be aimed at securing more votes.

The report outlines key steps and potential catalysts for the SAFE Act's progress:

  • Senate Banking Committee mark-up vote scheduled for late September.
  • Examination of how 11 Republicans in the Senate Banking Committee might vote.
  • Anticipation of changes or add-ons to the final bill before the mark-up vote.
  • Senate floor vote scheduled for November, with potential amendments.
  • Senate Majority Leader Chuck Schumer's role in bringing the bill for a vote.
  • Potential paths for passage if the Senate approves.

"If SAFE passes the Senate, there are two potential paths: a prolonged process until mid-2024 with House debates and votes, or a quicker passage through inclusion in a must-pass year-end bill. However, the likelihood of passage in the GOP-controlled House without overwhelming Senate support is low. Passage via the Omnibus or NDAA might offer a faster route," Zuanic wrote.

Low 60s In The Senate

It also recognizes potential derailing risks from including last-minute social equity add-ons or floor amendments in the Senate that could influence Republican support for the bill.

Tallying SAFE Supporters: A Congressional Headcount

As of September 18, 2023, the sponsors of the SAFE Banking Act include 71 members in the House (HR 2891: SAFE Banking Act of 2023), consisting of 52 Democrats and 19 Republicans.

Notably, Representative David Joyce (R-OH) serves as the Primary Sponsor among Republicans.

In the US Senate, there are 34 Senate Democrats and Independents (31+3) and eight Republican co-sponsors. Seven Republicans are co-sponsors, with Steve Daines (MT) serving as the lead sponsor.

The other Republican co-sponsors are Bill Cassidy (LA), Kevin Cramer (ND), Susan Collins (ME), Cynthia Lummis (WY), Lisa Murkowski (AK), Rand Paul (KY), and Dan Sullivan (AK).

To reach the required 60 votes in the Senate, the report goes through a process of elimination. According to Z&A, despite some optimism, it is challenging to believe claims that the SAFE Banking Act could secure over 70 votes in the Senate, with the most likely scenario being that it barely reaches 60 votes or even falls short.

Bottomline

The report estimates a 50-60% chance of success in the Senate and slightly better odds via a must-pass bill in the House at year-end, but less than a 40% chance if pursued as a standalone bill in the House next year.

Photo by Crissy Jarvis on Unsplash. 

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Analyst ColorCannabisGovernmentNewsRegulationsCommoditiesPoliticsExclusivesMarketsAnalyst RatingsGeneralPablo Zuanic
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter

The report delves into various scenarios and examines the critical role Senate Republicans play in securing the vital 60th vote for the SAFE Act, all while discussing the likelihood of achieving this support.

Don't miss your opportunity to connect with Pablo Zuanic, chief analyst at Zuanic & Associates, at the Benzinga Cannabis Capital Conference in Chicago on September 27-28, the place where deals get done. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.

Comments
Loading...